Delivery Order SPE2DB20D2104-SPE2DB23FR72W
Award Date 1/9/23
Potential Completion Date 1/10/23
Potential Value $20K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,085.54 firm fixed-price delivery order is for the supply of GLATOPA 40 MG/ML SYRINGE, a specialty medication. The award is a part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,007.43, is for the delivery of GLATOPA 20 MG/ML syringes. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $1,688.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product, with a completion date of April 14, 2023. The contract is a Delivery Order under a Firm Fixed Price arrangement. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit organization registered...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company AmerisourceBergen Corporation. The $10,538.64 firm fixed price delivery order is for the supply of GLATOPA 40 MG/ML syringes, a specialty pharmaceutical product. The award has a performance period through March 26, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp holds an...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,377.68 Firm Fixed Price delivery order is for the supply of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product. The contract has a period of performance through May 10, 2022 and does not include any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
- The Defense Logistics Agency awarded a delivery order valued at $4,146.82 to AmerisourceBergen Drug Corp for Glatopa 20 mg/ml syringes, with an ultimate completion date of December 31, 2025. This is a firm fixed price, non-set-aside contract issued as a child order under a larger indefinite delivery vehicle. The product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $16,739.80 delivery order is for GLATOPA 40 MG/ML SYRINGEML, which is a pharmaceutical product. The contract has an ultimate completion date of March 1, 2024 and is a firm fixed-price delivery order. The contract was awarded on February 29, 2024 and does not have a set-aside designation, indicating it was a full and open competition....
- AmerisourceBergen Drug Corp was awarded a delivery order contract on May 23, 2025, by the Defense Logistics Agency (DLA) for the supply of Glatopa 20 mg/ml syringes, valued at $11,106.64 under a firm fixed-price arrangement. The contract is non-competitive with no set-aside designation and is scheduled for completion by May 27, 2025. The product will be supplied from the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued against...
- This federal contract award, valued at $3,644.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Glatopa 20 mg/mL syringes, a medication used to treat multiple sclerosis. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency Troop Support Medical awarded a $18,634.86 firm fixed price delivery order to Amerisourcebergen Drug Corporation for GLATOPA 40 MG/ML SYRINGEML. The place of performance is Conshohocken, Pennsylvania. The period of performance is from August 2, 2023 through August 3, 2023. No additional details were provided regarding the original solicitation or whether this delivery order is associated with a larger indefinite-delivery/indefinite-quantity contract vehicle. The...